Cartesian Therapeutics Inc. (RNAC)
NASDAQ · Healthcare
Cartesian Therapeutics Inc. Cash on Hand 2014–2025
Cartesian Therapeutics Inc. annual cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Cartesian Therapeutics Inc. cash on hand as of December 31, 2025: 125.1M, a 41.14% decrease year-over-year.
- Cartesian Therapeutics Inc. cash on hand for 2025 were 125.1M, a 41.14% decrease from 2024.
- Cartesian Therapeutics Inc. cash on hand for 2024 were 212.6M, a 176.44% increase from 2023.
- Cartesian Therapeutics Inc. cash on hand for 2023 were 76.9M, a 27.74% decrease from 2022.
- Cartesian Therapeutics Inc. cash on hand for 2022 were 106.4M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cartesian Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $125 |
| 2024 | $213 |
| 2023 | $77 |
| 2022 | $106 |
| 2021 | $114 |
| 2020 | $139 |
| 2019 | $90 |
| 2018 | $37 |
| 2017 | $71 |
| 2016 | $59 |
| 2015 | $32 |
Cartesian Therapeutics Inc. Cash on Hand — FAQ
Cartesian Therapeutics Inc. (RNAC) cash on hand over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNAC's cash on hand history?
The chart and table above show Cartesian Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.